ADNEXUS has invested in Biomemory, a company developing revolutionary DNA-based data storage technology, to enhance sustainable data preservation in France.
Information on the Target
Biomemory is a pioneering company that leverages patented technology developed by the CNRS and Sorbonne University to create a revolutionary DNA-based storage solution. This innovative technology enables the retention of digital data for several centuries while maintaining a minimal environmental footprint. Biomemory's approach addresses the increasing demand from various businesses and institutions for secure and sustainable data preservation.
By harnessing the stability and density of DNA, Biomemory offers a unique solution for long-term data storage that not only meets current technological needs but also anticipates future challenges in data security and accessibility.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The digital data storage industry in France is experiencing rapid growth as organizations seek more reliable and eco-friendly solutions to handle their ever-increasing data needs. With the advent of big data, cloud comp
Similar Deals
Fonds Patient Autonome, Bpifrance, UNIQA, UI Investissement → Fizimed
2025
ADNEXUS
invested in
Biomemory
in 2024
in a Other VC deal